Fampridine is the first medicine designed to improve walking in adults with MS and will now be routinely available on the NHS from today, NHS England has announced. Taken as a pill twice a day, ...

NHS England » Landmark NHS approval of cancer drugs offers new hope for children and adults with rare blood cancers ...

The NHS will aim to prevent thousands of deaths from sepsis by 2035 as part of a series of measures to improve the treatment of the deadly condition. Sepsis is a life-threatening response to an ...

Listening and responding to our NHS people is as important as ever. The People Pulse is a national online pulse survey, developed to support local listening and employee engagement activities in the ...

“I hope this new policy supports people to work better together so that people with a learning disability and autistic people get the right support to stay well and have a good life”. Dr Roger Banks ...

This paper providers an update on NHS productivity. 1. The NHS England Public Board Paper on productivity in May 2024 and update in December 2024 set out the effect of the pandemic on NHS productivity ...

Tens of thousands of cancer patients have rated the care they received from the NHS as nearly 9 out of 10, as NHS teams see and treat record numbers of people for the disease. The latest patient ...

The last few years have seen significant change in how the NHS collects, processes, and reports costing information. This has been driven by the Costing Transformation Programme, which has delivered ...

This bulletin outlines simple measures to reduce energy use in operating theatres, helping the NHS save money, cut carbon emissions and improve efficiency. By implementing the recommendations, NHS ...

Freedom to Speak Up is one way of ensuring our NHS people have a voice that counts, which is central to our NHS People Promise. The following information clarifies the expectations of integrated care ...

A national programme of support for integrated care boards was launched in November 2023 to make use of valproate as safe as possible, striving to eliminate the harm it causes to babies in the womb, ...

The NHS Cancer Vaccine Launch Pad (CVLP) is a platform that will speed up access to messenger ribonucleic acid (mRNA) personalised cancer vaccine and other immunotherapy clinical trials for people who ...